Friday, March 6, 2026

Latest
Aspen Pharmacare Targets Canadian Market with Ozempic Generic by Q3 2026
Iran Warns European Nations Will Be ‘Legitimate Targets’ if They Join Conflict
Trump Predicts Imminent Fall of Cuba, Signals Potential Deal in CNN Interview
Strangers in Nairobi Are Watching Everything Your Meta Glasses See
US Treasury Quietly Lifts Sanctions to Free Stranded Russian Oil Bound for India
Caught in a War They Didn’t Choose, Gulf States Eye US Investment Pullback
Russia Reportedly Providing Iran With Intelligence To Target US Forces
US Weighs Shorting Oil Futures to Fight Price Surge
Carbon Policy Limbo Stalls $8.25B Canadian Natural Oil Sands Expansion
Bank of Canada Pilots $100M Tokenized Bond With TD And RBC
Search

Revive Therapeutics

Revive Therapeutics Considers Exploring Bucillamine For Treatment Of Monkeypox
August 29, 2024, 10:31:20 AM
Read More

Revive Therapeutics Announces Final Stages In Bucillamine Phase 3 Clinical Trial For COVID-19
January 19, 2022, 09:28:00 AM
Read More

Revive Therapeutics Adds Turkish Subjects To Bucillamine Phase 3 Clinical Trial For COVID-19
December 30, 2021, 12:49:00 PM
Read More

Revive Therapeutics Includes Treating Omicron Variant In Bucillamine Research
December 3, 2021, 02:56:00 PM
Read More

Revive Therapeutics Announces Research Collaboration Agreement For Psilocybin Microneedle Patch
November 3, 2021, 09:29:00 AM
Read More

Revive Therapeutics Enters Exclusive License For Ganoderma Lucidum Intellectual Property
August 18, 2021, 09:23:10 AM
Read More

Revive Therapeutics Provides Update On Current Psilocybin Programs
August 10, 2021, 08:36:06 AM
Read More

Revive Therapeutics Begins Laying Groundwork For Commercialization Of Bucillamine
July 15, 2021, 02:27:50 PM
Read More

Revive Therapeutics Partners With University of Health Sciences Antigua To Further Psychedelics Research
June 17, 2021, 08:45:27 AM
Read More

Revive Therapeutics Looks To Bring Bucillamine To India
June 8, 2021, 09:15:00 AM
Read More
Latest News
Aspen Pharmacare Targets Canadian Market with Ozempic Generic by Q3 2026
Iran Warns European Nations Will Be ‘Legitimate Targets’ if They Join Conflict
Trump Predicts Imminent Fall of Cuba, Signals Potential Deal in CNN Interview
Strangers in Nairobi Are Watching Everything Your Meta Glasses See
US Treasury Quietly Lifts Sanctions to Free Stranded Russian Oil Bound for India
Caught in a War They Didn’t Choose, Gulf States Eye US Investment Pullback
Russia Reportedly Providing Iran With Intelligence To Target US Forces
US Weighs Shorting Oil Futures to Fight Price Surge
Carbon Policy Limbo Stalls $8.25B Canadian Natural Oil Sands Expansion
Bank of Canada Pilots $100M Tokenized Bond With TD And RBC
Video Articles

Is This the Most Overlooked Critical Mineral? (+1000% Move) | Guy Bourassa – Scandium Canada

Is Gold Entering a New 15-Year Cycle? | Rob Husband

A 100,000 Ounce Per Year Gold Plan in Utah | Scott Trebilcock — Revival Gold
Recommended

Silver47 Launches 7,000-Meter Hughes Drill Program In Nevada

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver
Trending
© 2026
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.